|
COVID - 19 |
14151 |
(Revised) Sickle cell trait and the Risk of Severe COVID-19 in individuals of African ancestry |
Alex Reiner |
|
COVID - 19 |
14743 |
ABO Blood Group and the Risk of Severe COVID-19 |
Debora Kamin Mukaz |
|
COVID - 19 |
18327 |
COVID-19 Genetic Risk Score and associations with COVID-19 related outcomes: the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program and the C4R Study |
Tess D. Pottinger |
|
COVID - 19 |
14109 |
Genome-wide association study of antibody titer in response to SARS-CoV-2 vaccination |
Laura Raffield |
|
COVID - 19 |
10099 |
Mechanisms Linking Blood Type, Blood Proteins, and COVID-19: Insights from the Integration of Proteomics and Genetics in the Jackson Heart Study |
Daniel H Katz |
|
COVID - 19 |
10118 |
Mechanisms Linking Blood Type, Blood Proteins, and COVID-19: Insights from the Integration of Proteomics and Genetics in the Jackson Heart Study |
Daniel H Katz |
|
COVID - 19 |
20286 |
Polygenic Cardiovascular Risk and COVID-19 related outcomes: the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program and the C4R Study |
Tess Peterson |
|
COVID - 19 |
14127 |
Sickle cell trait and the Risk of Severe COVID-19 in individuals of African ancestry |
Alex Reiner |
